ChemBriefEli Lilly to Acquire Narcolepsy Drug Developer for $6.3 Billion
Mar 31, 2026
Eli Lilly will acquire Centessa Pharmaceuticals for $6.3 billion, with an additional $1.5 billion contingent on FDA approval of its narcolepsy drug candidates. Analysts believe the acquired drug has blockbuster potential.
2026-02-03
Feb. 3 Business Watch: Catalysis start-ups raise money; Lilly strikes deals with 2 biotech firms2026-04-30
Lilly lifts profit forecast as surging demand for weight-loss drugs offsets pricing pressure2026-04-30
US Premarket Movers for April 30, 20262026-05-21
US Premarket Movers for May 21, 2026Show all 18 updates